Case report · 10 Aug 2026
Research articlePublished 24 Jan 2023
Treatment Burden for Older People with Multimorbidity: A Cross-Sectional Study in China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: There has been little research in China about treatment burden. Studies internationally have found high treatment burden is associated with number of long-term conditions, low Quality of Life (QoL) and poor medication adherence. The purpose of this study is to understand factors associated with high treatment burden for older people with multimorbidity in China. Methods: Cross-sectional survey was conducted from February to May 2022. Through convenience sampling, 353 older people (≥ 60 years) with multimorbidity (≥ 2 long term conditions) admitted to hospital in Zhengzhou, China, were invited to complete a survey including sociodemographic characteristics, long-term conditions and the Chinese version of Multimorbidity Treatment Burden Questionnaire (C-MTBQ). Ordinal logistic regression was used to identify the factors associated with high treatment burden. Results: 342 older people with multimorbidity participated (response rate 92.2%) among whom, the prevalence of no,low, medium and high treatment burden was 1.2% (4/342), 13.9% (44/342), 49.1% (168/342) and 36.8% (126/342), respectively. Ordinal logistic regression analysis found high treatment burden was associated with age, monthly household income, type of medical insurance and number of long-term conditions. Conclusion: Most surveyed older people with multimorbidity experienced medium to high treatment burden. Interventions to reduce treatment burden for people with multimorbidity in China, should focus particularly on people at risk of higher treatment burden, namely older people with low income and high number of long-term conditions.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.
More from this journal
The newest in Journal of Clinical Trials.
Short communication · 31 Jul 2026
Understanding Bioavailability as a Key Element in Effective Therapeutic Delivery
Research article · 14 Jun 2026
Ensuring Rights and Dignity in Ethical Practices of Clinical Studies with Vulnerable Group and Safeguarding Vulnerable Group Act (2006)
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Trials
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Liyuan Dou”
- BylineArticles whose byline prints “Qiuling Jiang”
- BylineArticles whose byline prints “Polly Duncan”
- BylineArticles whose byline prints “Xiaoping Li”
